News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Chlormadinone prolongs active surveillance, maintains QoL in men with prostate cancer
05 Nov 2021
byAudrey Abella
Use of the oral antiandrogen chlormadinone at a low dose led to improvements in persistence rate of active surveillance (AS), PSA* and testosterone levels and prostate volume, and quality of life (QoL) in men with low-risk prostate cancer (PCa), the PROSAS study has shown.








